Navigate the complexity of dermatology drug development with our experienced global team. Across Phases I-IV, we advance your dermatology clinical study, helping you transform patients’ lives.
To address the challenges of dermatology clinical research, you need a dedicated partner who can efficiently access the right patient population, provide consistency in your dermatological assessments, and deliver quality data.
As a full-service, global CRO, we apply our “fit-for-purpose” approach to provide scalable cross-functional support and deliver the right resources—at the right time—to advance your pharmaceutical development. Whether you need specific study services or end-to-end capabilities, we work to bring your science to life and help you make a difference for people living with dermatological diseases.
Our history of success in dermatology programs spans more than 1,200 sites and 6,500 patients. We’ve helped our clients advance studies in a variety of indications, such as atopic dermatitis, alopecia areata, psoriasis, vitiligo, hidradenitis suppurativa, and more. By collaborating with our scientific and operational experts, you’ll gain insights from our in-house dermatologist, medical monitors, and global dermatology expertise, which includes experience from several dermatology studies in China.
At Caidya, we believe the best client outcomes start with a collaborative partnership. Our Dermatology team of operational, clinical, and medical specialists is led by Lori Lombardo, VP & Therapeutic Area Leader, Dermatology and General Medicine. Having built a Dermatology Business Unit at a previous CRO, Lori now leads Caidya’s Dermatology portfolio. With more than 28 years of experience in both pharma and CROs, Lori’s clinical development, project and program management, and insights into a wide range of dermatology indications distinctly position her to help sponsors advance their dermatology programs.
“Dermatology advancements change lives, which is extremely exciting. With each dermatology clinical study, our team becomes fully invested in our client’s success to reach those important moments for patients.”
Lori Lombardo, VP & Therapeutic Area Leader, Dermatology and General Medicine
From the start, we bring a patient-centric focus to your dermatology study. To reduce patient burden and enhance retention, we evaluate your protocol design and thoughtfully balance protocol requirements with patient preferences. Whether you want to employ remote visual assessments, in-home mobile services, or digital health technologies, our team is here to help you incorporate decentralized clinical study solutions that increase patient engagement and retention in your study.
We proactively address the challenge of finding the right patient population for your dermatology study. Drawing on our lessons learned from advancing rare disease studies, we connect with dermatology advocacy groups, develop trusted relationships with sites, and provide thorough patient education and training.
Your dermatology study relies on standardized data collection to generate quality data from visual endpoints, patient-reported outcomes, and investigator questionnaires. We start with the end in mind, focusing first on training sites, patients, and raters to improve the quality of your qualitative and quantitative data.
We also confirm that your data will be collected from validated assessments that ultimately support your approval process. Finally, as large datasets arrive, our team is equipped to manage, clean, and integrate your global data to keep your study on track.
Ready for the next step in your drug development journey? Learn more about how our personalized solutions can help you enable better healthcare outcomes.
Explore our news and updates as we liberate the clinical research process.
News
03/13/2025
News
01/28/2025
News
01/13/2025